Rakuten Medical, a developer of cancer treatments partly owned by Japan’s Rakuten Group, completed a fundraising round as it aims to accelerate approval for its cancer treatment in the U.S.
Source link
About The Author
Rakuten Medical Raises $100 Million in Fundraising Round